# South America Vascular Embolization Market > South America Vascular Embolization Market Size, Growth Research Report Byy Embolization Technique (Coiling Devices, Non-coiling Devices), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) and By Region (Brazil, Mexico, Argentina, Rest of South America) - Competitor Industry Analysis and Trends Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.9% - **2024:** $ 208.81 Million - **2025:** $ 229.49 Million - **2035:** $ 589.96 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cook Medical (US), AngioDynamics (US) **Report ID:** MRFR/HC/50300-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-america-vascular-embolization-market-52058 --- ## Market Summary ## **South America Vascular Embolization Market Overview** As per MRFR analysis, the South America Vascular Embolization Market Size was estimated at 190.17 (USD Million) in 2023. The South America Vascular Embolization Market Industry is expected to grow from 209(USD Million) in 2024 to 590 (USD Million) by 2035. The South America Vascular Embolization Market CAGR (growth rate) is expected to be around 9.894% during the forecast period (2025 - 2035). ### **Key South America Vascular Embolization Market Trends Highlighted** The primary factors driving the South America Vascular Embolisation Market are the increasing prevalence of vascular diseases and the ageing population, which are leading to a higher incidence of conditions necessitating embolisation procedures. Furthermore, the region has seen a rise in the adoption of embolisation procedures as a result of the advancements in medical technology, particularly image-guided therapies and minimally invasive techniques. Governments are also promoting improvements to healthcare infrastructure in countries such as Argentina and Brazil, which enables improved access to advanced medical treatments.  Additionally, there are substantial opportunities to be investigated in the field of ambulatory care services, as healthcare providers are providing day surgeries and minimally invasive treatments, which are attracting a greater number of patients. The market is anticipated to expand due to the ongoing investment in healthcare systems, particularly with the introduction of new product lines that target specific vascular diseases. In recent years, there has been a distinct trend towards the integration of digital health technologies, including health information systems and telemedicine, to facilitate improved patient monitoring and follow-ups following embolism procedures.  Furthermore, the region is experiencing an increase in the prevalence of partnerships among key stakeholders, which is promoting the adoption of cutting-edge embolisation techniques and fostering innovation. In general, the vascular embolisation market in South America is undergoing a rapid transformation, which is being fueled by a convergence of healthcare requirements, technological advancements, and a commitment to enhancing patient outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **South America Vascular Embolization Market Drivers** Rising Incidence of Cardiovascular Diseases The South America Vascular Embolization Market is experiencing growth driven by the increasing prevalence of cardiovascular diseases. According to the Pan American Health Organization, cardiovascular diseases account for approximately 30% of all deaths in South America. The demand for vascular embolization procedures is expected to rise as healthcare providers seek to address this urgent health concern. Organizations such as the Brazilian Society of Cardiology are actively promoting awareness and treatment options, leading to higher procedural rates. As the South American population continues to age, the need for effective treatment modalities, including vascular embolization, sits prominently within the agenda for healthcare systems, encouraging investments in related technologies and services. Technological Advancements in Medical Devices Technological innovation plays a significant role in driving the South America Vascular Embolization Market forward. The introduction of advanced embolization devices such as micro-coils, liquid embolics, and drug-eluting beads is enhancing treatment outcomes in vascular procedures. According to a report from ANVISA, the Brazilian Health Regulatory Agency, the clearance of novel embolization products has increased by 45% in recent years. This increase signifies a growing acceptance of innovative technologies by healthcare professionals in South America, pushing providers to adopt and invest in new therapies that enhance patient outcomes and reduce recovery times. Growing Demand for Minimally Invasive Procedures The demand for minimally invasive procedures is escalating within the South America Vascular Embolization Market Industry due to increased awareness about patient outcomes and recovery times. Research by the Latin American Society of Interventional Radiology indicates that patients prefer options that minimize hospital stays and lead to faster recovery periods. Hospitals and healthcare providers in South America are therefore investing in training staff and equipping facilities with necessary technologies to meet this growing demand. Reports suggest that minimally invasive vascular procedures have surged by over 25% in the last five years, further propelling the market forward. This trend is also supported by various surgical associations advocating for the integration of less invasive interventions in patient care. ## **South America Vascular Embolization Market Segment Insights** ### **Vascular Embolization Market Embolization Technique Insights** The South America Vascular Embolization Market, particularly focusing on Embolization Technique, has been witnessing significant advancements largely driven by the increased prevalence of vascular diseases, coupled with a rise in minimally invasive procedures. The market offers distinct categories, primarily Coiling Devices and Non-coiling Devices, which cater to various clinical needs in vascular embolization. Coiling Devices have carved a significant position in the market as they efficiently treat certain types of aneurysms and vascular malformations, thanks to their ability to provide targeted treatment with reduced recovery time for patients. The effectiveness of these devices in occluding blood vessels enhances their adoption among healthcare providers.  Non-coiling Devices, on the other hand, represent a crucial part of the embolization landscape, serving a broad spectrum of applications, including uterine fibroids and benign prostatic hyperplasia. Their growing utilization can be linked to the increasing awareness and acceptance of embolization procedures among patients, fostering a conducive environment for the growth of both categories. Additionally, the South America region is progressively investing in healthcare infrastructure and innovation, leading to enhanced accessibility and adoption of advanced therapeutic techniques like those found in embolization.  Government initiatives aimed at improving healthcare outcomes can create new opportunities for market expansion in the embolization sector. Furthermore, the rising geriatric population in South America catalyzes market growth, as older adults are more susceptible to vascular disorders. Overall, the emphasis on patient safety and effective treatment modalities makes the Embolization Technique segment a vital area of interest in the South America Vascular Embolization Market, highlighting its potential to transform patient care outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Vascular Embolization Market Application Insights** The South America Vascular Embolization Market, particularly in the Application segment, showcases a diverse array of medical applications including Peripheral Vascular Disease, Oncology, Neurology, Urology, and other areas. Peripheral Vascular Disease has gained significant traction owing to the rising prevalence of lifestyle-related health issues, prompting increased demand for innovative treatment options. Oncology is also a crucial application, driven by the high incidence of cancer cases, necessitating advanced embolization techniques for effective tumor management.Neurology has emerged as a vital segment, where embolization is pivotal in treating conditions like arteriovenous malformations and aneurysms, reflecting the growing focus on neurological disorders in South America.  Urology presents substantial opportunities as well, particularly in managing renal tumors, enhancing patient outcomes through minimally invasive procedures. Other applications encompass a variety of vascular conditions, contributing to the overall market dynamics. As the healthcare infrastructure improves in South America, the continuous evolution of technology and techniques will drive further growth in this segment, aligning with the region's healthcare objectives and enhancing patient care across various medical fields. ### **Vascular Embolization Market Regional Insights** The South America Vascular Embolization Market showcases significant regional dynamics, primarily driven by Brazil, Mexico, Argentina, and the Rest of South America. Brazil holds a substantial position in the market, being a key player due to its advanced healthcare infrastructure and a growing prevalence of vascular diseases. Meanwhile, Mexico is emerging as a vital market contributor, benefiting from increasing healthcare investments and a rising demand for minimally invasive procedures. Argentina also plays a pivotal role, particularly with its emphasis on modernizing healthcare services to improve patient outcomes. The Rest of South America presents a diverse landscape, showcasing varied growth opportunities across different nations. Collectively, the South America Vascular Embolization Market reflects strong growth potential driven by factors such as technological advancements in embolization devices and increasing awareness of these procedures. Furthermore, challenges like regulatory approvals and market entry barriers persist, but the overall outlook remains positive, contributing to a vibrant market landscape in this region. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **South America Vascular Embolization Market Key Players and Competitive Insights** The South America Vascular Embolization Market is characterized by a competitive landscape that is rapidly evolving due to the increasing need for minimally invasive procedures, advancements in healthcare technology, and the rising prevalence of vascular diseases. As healthcare providers look for effective treatment options to improve patient outcomes, these factors influence the dynamics of the market. The competitive insights within this area are shaped by a diverse group of manufacturers and suppliers who are striving to innovate and differentiate their products. Companies are investing in research and development to enhance their offerings and capture a larger market share. Additionally, strategic partnerships and collaborations are frequently observed as companies aim to streamline their operations and extend their reach across the region. AngioDynamics has established a strong presence in the South America Vascular Embolization Market, driven by its commitment to delivering high-quality medical devices for vascular interventions. The company focuses on innovation and has a diverse portfolio that addresses various vascular conditions, enhancing its appeal to healthcare professionals and patients. AngioDynamics is well-regarded for its cutting-edge technologies and solutions for embolization procedures, which have gained traction among medical practitioners in the region. The company's strengths lie in its strong brand recognition, a robust distribution network, and ongoing efforts in clinical education and training, which further reinforce its foothold in the market. By effectively addressing local healthcare challenges and leveraging its product advantages, AngioDynamics positions itself as a key player in this competitive landscape. Volcano Corporation, with its specialized focus on advanced vascular imaging and therapeutic solutions, also plays a significant role in the South America Vascular Embolization Market. The company is renowned for its innovative products, such as interventional imaging systems and catheter-based systems, which are tailored to enhance procedural efficiency and precision during embolization treatments. Volcano Corporation has a noteworthy market presence due to its commitment to advancing clinical practices through technological innovations.  The company has solidified its strengths by continuously improving its product offerings based on feedback from healthcare professionals. In South America, Volcano Corporation's strategy may involve forming strategic alliances and conducting mergers and acquisitions with regional players to enhance its market position and expand its service capabilities. This approach not only broadens its product range but also reinforces its commitment to delivering superior healthcare solutions tailored to the unique needs of the South American medical landscape. **Key Companies in the South America Vascular Embolization Market Include** ## **South America Vascular Embolization Market Industry Developments** Recent developments in the South America Vascular Embolization Market have shown a significant increase in demand for minimally invasive procedures, driven largely by rising cases of vascular diseases and advancements in technology. Companies such as AngioDynamics and Boston Scientific are expanding their product lines to enhance embolization techniques. Notably, in August 2023, Abbott Laboratories launched a new embolization device specifically designed for use in the South American market, aiming to cater to the growing patient population.Currently, the market is witnessing substantial investments in Research and Development initiatives by firms like Medtronic and Stryker, focusing on innovative embolization solutions.  Additionally, in July 2023, Terumo announced a strategic partnership with a local medical institution in Brazil to improve patient access to their embolization products, emphasizing the collaborative approach to healthcare solutions in the region.Mergers and acquisitions have also been a focal point, with Merit Medical Systems acquiring a prominent vascular technology firm in June 2023 to strengthen its position in South America. This acquisition highlights the competitive landscape of the market as companies aim to consolidate resources and expertise. The overall growth in market valuation reflects the increasing recognition of vascular embolization treatments as vital in improving patient outcomes in South America. ## **South America Vascular Embolization Market Segmentation Insights** ### **Vascular Embolization Market Embolization Technique****Outlook** ## **Vascular Embolization Market Application****Outlook** ### **Vascular Embolization Market Regional****Outlook** ## Market Drivers ### Aging Population The demographic shift towards an aging population in South America significantly influences the vascular embolization market. As individuals age, the prevalence of vascular diseases, such as aneurysms and arteriovenous malformations, tends to increase. By 2025, it is estimated that over 15% of the population in South America will be aged 65 and older, creating a larger patient base requiring vascular interventions. This demographic trend necessitates the development and availability of effective treatment options, including embolization procedures. The vascular embolization market is likely to see a surge in demand as healthcare providers seek to address the unique needs of older patients, who often present with complex medical conditions. Additionally, the growing awareness of vascular health among the elderly population may lead to earlier diagnosis and treatment, further driving market growth. ### Rising Awareness and Education In South America, increasing awareness and education regarding vascular health are crucial drivers for the vascular embolization market. Public health campaigns and educational initiatives by healthcare organizations are enhancing knowledge about vascular diseases and the benefits of embolization procedures. As a result, patients are becoming more proactive in seeking treatment options. In 2025, surveys indicate that approximately 60% of the population is aware of minimally invasive procedures, compared to just 30% in previous years. This heightened awareness is likely to lead to increased consultations with healthcare providers and a subsequent rise in the demand for vascular embolization treatments. Furthermore, as more patients understand the advantages of these procedures, such as reduced recovery times and lower complication rates, the vascular embolization market is expected to experience robust growth. ### Increasing Healthcare Expenditure The rising healthcare expenditure in South America is a pivotal driver for the vascular embolization market. Governments and private sectors are investing more in healthcare infrastructure, which enhances access to advanced medical technologies. In 2025, healthcare spending in the region is projected to reach approximately $500 billion, reflecting a growth rate of around 5% annually. This increase in funding allows hospitals and clinics to acquire state-of-the-art embolization devices and training for healthcare professionals. Consequently, the vascular embolization market benefits from improved patient outcomes and expanded treatment options, as more facilities adopt these innovative procedures. Furthermore, as healthcare budgets grow, there is a greater emphasis on minimally invasive techniques, which are often associated with shorter recovery times and reduced hospital stays, further propelling the demand for vascular embolization solutions. ### Supportive Regulatory Environment A supportive regulatory environment in South America plays a vital role in fostering the growth of the vascular embolization market. Regulatory bodies are increasingly recognizing the importance of minimally invasive procedures and are streamlining the approval processes for new embolization devices. This trend is likely to encourage innovation and investment in the sector. In 2025, it is anticipated that the approval timelines for new medical devices will decrease by approximately 20%, facilitating quicker access to advanced treatment options for patients. Furthermore, regulatory support often includes guidelines that promote best practices in embolization procedures, enhancing safety and efficacy. As a result, healthcare providers are more inclined to adopt these technologies, thereby driving the demand for vascular embolization solutions in the region. ### Technological Innovations in Medical Devices Technological innovations in medical devices are transforming the landscape of the vascular embolization market in South America. The introduction of advanced embolization materials, such as bioresorbable particles and novel delivery systems, enhances the efficacy and safety of procedures. In 2025, the market for embolization devices is projected to grow at a CAGR of 7%, driven by these innovations. Additionally, the integration of imaging technologies, such as 3D imaging and real-time monitoring, allows for more precise and effective embolization procedures. As healthcare providers adopt these cutting-edge technologies, patient outcomes improve, leading to increased satisfaction and a higher likelihood of recommending these treatments. Consequently, the vascular embolization market is poised for significant expansion as technological advancements continue to shape the future of vascular interventions. ## Future Outlook The [Vascular Embolization Market](https://www.marketresearchfuture.com/reports/vascular-embolization-market-11872) is projected to grow at a 9.9% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable embolic agents for enhanced patient safety. - Expansion of telemedicine platforms for remote embolization consultations. - Investment in AI-driven imaging technologies to improve procedural accuracy. By 2035, the vascular embolization market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing) In the South America vascular embolization market, coiling devices hold the largest share, reflecting their established presence and preference among medical practitioners. These devices have gained popularity due to their effectiveness in treating various vascular malformations, contributing significantly to their market penetration. On the other hand, non-coiling devices are emerging as a strong contender, appealing to a growing segment of healthcare providers and patients seeking innovative treatment options. This dual dynamic underscores the competitive nature of the market. Growth trends in this segment are propelled by advancements in technology and increased awareness of minimally invasive procedures. Coiling devices are experiencing steady demand, driven by their proven efficacy, while non-coiling devices are characterized by rapid technological innovations that enhance their appeal. With a focus on patient outcomes and procedural effectiveness, both segments are expected to witness significant transformation as healthcare professionals increasingly adopt new techniques to improve treatment success rates. Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging) Coiling devices are well-established in the South America vascular embolization market due to their effectiveness in occluding blood vessels. They dominate the segment by offering reliable solutions for treating conditions such as aneurysms and arteriovenous malformations. Their market strength stems from their long history of use, proven safety profiles, and favorable patient outcomes. Conversely, non-coiling devices are emerging as innovative alternatives, incorporating advanced technologies like liquid embolics and bio-absorbable materials. As these devices gain traction among clinicians, they represent the future of embolization techniques, appealing to a growing patient demographic keen on effective and less invasive treatment methodologies. ### By Application: Peripheral Vascular Disease (Largest) vs. Oncology (Fastest-Growing) In the South America vascular embolization market, Peripheral Vascular Disease accounts for the largest share of the application segment, indicating a significant patient population and a well-established treatment pathway. This segment continues to attract investment due to its widespread occurrence and advanced procedural techniques that enhance patient outcomes. In contrast, the Oncology application is rapidly gaining traction, driven by increasing cancer incidences and the expanding use of embolization techniques in targeted cancer therapies. The growth trends within these applications showcase a marked shift towards the Oncology segment, which is primarily fueled by technological advancements in embolization devices and a growing emphasis on minimally invasive procedures. As healthcare systems adapt to include innovative treatments, the demand in the Oncology segment is expected to rise significantly, positioning it as the fastest-growing application in this market, while Peripheral Vascular Disease remains a cornerstone of the sector. Peripheral Vascular Disease (Dominant) vs. Oncology (Emerging) Peripheral Vascular Disease represents a dominant force in the application landscape, characterized by a robust infrastructure supporting diagnosis, treatment, and management. The established nature of the techniques used allows for dependable outcomes and widespread acceptance among healthcare providers. Conversely, the Oncology segment, while currently emerging, is experiencing rapid growth due to increased research and the introduction of innovative embolization therapies aimed at specific tumors. The focus on personalized medicine and increased funding for cancer treatment initiatives are propelling its expansion, making it a critical area for development and investment within the vascular embolization market. ## Regional Market Share Analysis The South America Vascular Embolization Market showcases significant regional dynamics, primarily driven by Brazil, Mexico, Argentina, and the Rest of South America. Brazil holds a substantial position in the market, being a key player due to its advanced healthcare infrastructure and a growing prevalence of vascular diseases. Meanwhile, Mexico is emerging as a vital market contributor, benefiting from increasing healthcare investments and a rising demand for minimally invasive procedures. Argentina also plays a pivotal role, particularly with its emphasis on modernizing healthcare services to improve patient outcomes. The Rest of South America presents a diverse landscape, showcasing varied growth opportunities across different nations. Collectively, the South America Vascular Embolization Market reflects strong growth potential driven by factors such as technological advancements in embolization devices and increasing awareness of these procedures. Furthermore, challenges like regulatory approvals and market entry barriers persist, but the overall outlook remains positive, contributing to a vibrant market landscape in this region. ## Competitive Benchmarking The vascular embolization market in South America is characterized by a dynamic competitive landscape, driven by increasing demand for minimally invasive procedures and advancements in medical technology. Key players such as Medtronic (US), Boston Scientific (US), and Terumo Corporation (JP) are strategically positioned to leverage innovation and regional expansion. Medtronic (US) focuses on enhancing its product portfolio through continuous research and development, while Boston Scientific (US) emphasizes strategic partnerships to broaden its market reach. Terumo Corporation (JP) appears to be concentrating on localizing manufacturing to better serve the South American market, thereby enhancing its operational efficiency and responsiveness to regional needs.The market structure is moderately fragmented, with several players vying for market share. This fragmentation is indicative of a competitive environment where companies are increasingly localizing manufacturing and optimizing supply chains to reduce costs and improve service delivery. The collective influence of these key players shapes the market dynamics, as they engage in various tactics to enhance their competitive positioning. In October Medtronic (US) announced the launch of a new embolization device designed specifically for the treatment of vascular malformations. This strategic move is likely to strengthen Medtronic's (US) foothold in the South American market, as it addresses a critical need for innovative solutions in vascular interventions. The introduction of this device not only showcases Medtronic's (US) commitment to innovation but also positions the company to capture a larger share of the growing demand for embolization procedures. In September Boston Scientific (US) entered into a partnership with a local healthcare provider in Brazil to enhance access to its embolization products. This collaboration is significant as it allows Boston Scientific (US) to leverage local expertise and distribution networks, thereby improving its market penetration. Such strategic alliances are essential for navigating the complexities of the South American healthcare landscape, where localized knowledge can drive success. In August Terumo Corporation (JP) expanded its manufacturing capabilities in Argentina, aiming to increase production capacity for its embolization products. This expansion is indicative of Terumo's (JP) long-term commitment to the region and its strategy to meet the rising demand for vascular interventions. By localizing production, Terumo (JP) not only reduces lead times but also enhances its ability to respond to market fluctuations effectively. As of November the competitive trends in the vascular embolization market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing innovation and market reach. Looking ahead, the competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the vascular embolization market. ## Recent News & Developments Recent developments in the South America Vascular Embolization Market have shown a significant increase in demand for minimally invasive procedures, driven largely by rising cases of vascular diseases and advancements in technology. Companies such as AngioDynamics and Boston Scientific are expanding their product lines to enhance embolization techniques. Notably, in August 2023, Abbott Laboratories launched a new embolization device specifically designed for use in the South American market, aiming to cater to the growing patient population.Currently, the market is witnessing substantial investments in Research and Development initiatives by firms like Medtronic and Stryker, focusing on innovative embolization solutions.  Additionally, in July 2023, Terumo announced a strategic partnership with a local medical institution in Brazil to improve patient access to their embolization products, emphasizing the collaborative approach to healthcare solutions in the region.Mergers and acquisitions have also been a focal point, with Merit Medical Systems acquiring a prominent vascular technology firm in June 2023 to strengthen its position in South America. This acquisition highlights the competitive landscape of the market as companies aim to consolidate resources and expertise. The overall growth in market valuation reflects the increasing recognition of vascular embolization treatments as vital in improving patient outcomes in South America. ## Report Scope | MARKET SIZE 2024 | 208.81(USD Million) | | --- | --- | | MARKET SIZE 2025 | 229.49(USD Million) | | MARKET SIZE 2035 | 589.96(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cook Medical (US), AngioDynamics (US) | | Segments Covered | Technique, Application | | Key Market Opportunities | Emerging technologies in vascular embolization enhance treatment efficacy and patient outcomes in South America. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in vascular embolization technologies across South America. | | Countries Covered | Brazil, Mexico, Argentina, Rest of South America | ## Frequently Asked Questions **Q: What was the market valuation of the vascular embolization market in 2024?** A: The market valuation was $208.81 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The projected market valuation for 2035 is $589.96 Million. **Q: What is the expected CAGR for the vascular embolization market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 9.9%. **Q: Which companies are considered key players in the vascular embolization market?** A: Key players include Medtronic, Boston Scientific, Terumo Corporation, Johnson & Johnson, Stryker Corporation, Abbott Laboratories, B. Braun Melsungen AG, Cook Medical, and AngioDynamics. **Q: What were the valuations for coiling and non-coiling devices in 2024?** A: In 2024, coiling devices were valued at $83.53 Million, while non-coiling devices were valued at $125.28 Million. **Q: How do the applications of vascular embolization break down in terms of market valuation?** A: In 2024, oncology applications were valued at $60.0 Million, neurology at $50.0 Million, peripheral vascular disease at $40.0 Million, urology at $30.0 Million, and other applications at $28.81 Million. **Q: What is the expected growth trend for the vascular embolization market in South America?** A: The market appears to be on a growth trajectory, with projections indicating a substantial increase by 2035. **Q: How does the vascular embolization market in South America compare to other regions?** A: While specific comparisons are not provided, the growth rate of 9.9% suggests a robust market potential in South America. **Q: What factors might influence the growth of the vascular embolization market in the coming years?** A: Factors such as advancements in medical technology, increasing prevalence of vascular diseases, and rising healthcare expenditure may influence market growth. **Q: What is the significance of the vascular embolization market for healthcare providers in South America?** A: The market's growth indicates potential opportunities for healthcare providers to enhance treatment options and improve patient outcomes. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-vascular-embolization-market-52058*